The new update will become part of NIOSH's program called Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. According to NIOSH research biologist Thomas Connor, the new list will include about 100 new drug candidates for the list, most of which ...
Smith, S. T., & Szlaczky, M. C. (2015). Syringe plunger contamination by hazardous drugs: A comparative study.Journal of Oncology Pharmacy Practice. Karmanos Cancer Center, Detroit, USA. Retrieved from: https://www.equashield.com/clinical-studies/syringe-plunger-contamination-by-hazardous-drug...
1. NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. 2004. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOS...
The document builds on a NIOSH alert from 2004 that warned health care employers and workers of the risks of working with hazardous drugs and also identified measures they could take to protect their health.
In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that have generated lists of hazardous drugs for their respective facilities and by the Pharmaceutical Research and Manufacturers of America (Ph...
In this study we aim to review the presence in the environment of the hazardous drugs (NIOSH group 1) and their possible environmental impact. Of the 90 drugs considered, there is evidence of presence in the environment for 19. Drugs with more studies reporting positive detections are: the ...
A correction to the article "Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012" published in the June 27, 2012 issue of the journal is presented.HowardJohnEBSCO_bspFederal RegisterNIOSH, NIOSH List of Antineoplastic and Other Hazardous Drugs...
NIOSH [2016]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. By Connor TH, MacKenzie BA, DeBord DG, Trout DB, O'Callaghan JP. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Di- sease Control and Prevention, National ...
In this study we aim to review the presence in the environment of the hazardous drugs (NIOSH group 1) and their possible environmental impact. Of the 90 drugs considered, there is evidence of presence in the environment for 19. Drugs with more studies reporting positive detections are: the ...
National Institute for Occupational Safety and Health is publishing a document titled ''NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012."HowardJohnFederal RegisterNational Institute for Occupational Safety and Health. (2012). NIOSH list of antineoplastic and other ...